Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European- and African-American smokers

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 3, 2007, Pages 285-290

  Beuten, Joke ^a,c   Ma, Jennie Z ^a   Lou, Xiang Yang ^a   Payne, Thomas J ^b   Li, Ming D ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Association analysis; Haplotype; Nicotine dependence; PPP1R1B; SNP; Tobacco smoking

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; DISEASE ASSOCIATION; EUROPEAN AMERICAN; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MESOLIMBIC DOPAMINERGIC SYSTEM; NUCLEAR FAMILY; PPP1R1B GENE; PRIORITY JOURNAL; REGULATOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS; TOBACCO DEPENDENCE;

ADULT; AFRICAN AMERICANS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TOBACCO USE DISORDER; UNITED STATES;

NICOTIANA TABACUM;

EID: 34247391032     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30399     Document Type: Article

References (46)

1. Balfour DJ, Wright AE, Benwell ME, Birrell CE. 2000. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113:73-83.
2. Bamshad M, Wooding S, Salisbury BA, Stephens JC. 2004. Deconstructing the relationship between genetics and race. Nat Rev Genet 5:598-609.
3. Barrett JC, Fry B, Mailer J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4. Benowitz NL. 1988. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319:1318-1330.
5. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P III. 1999. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 291:1196-1203.
6. Beuten J, Ma JZ, Payne TJ, Dupont RT, Crews KM, Somes G, Williams NJ, Elston RC, Li MD. 2005. Single- and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 76:859-864.
7. Brene S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. 1994. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J Neurosci 14:985-998.
8. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N. 2003. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348:1170-1175.
9. Corrigall WA, Franklin KB, Coen KM, Clarke PB. 1992. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107:285-289.
10. Edwards KL, Austin MA, Jarvik GP. 1995. Evidence for genetic influences on smoking in adult women twins. Clin Genet 47:236-244.
11. Ezzati M, Lopez AD. 2003. Estimates of global mortality attributable to smoking in 2000. Lancet 362:847-852.
12. Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P. 1998. DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission. Science 281:838-842.
13. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
14. Goode EL, Badzioch MD, Kim H, Gagnon F, Rozek LS, Edwards KL, Jarvik GP. 2003. Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study. BMC Genet 4 Suppl 1:S102.
15. Halpain S, Girault JA, Greengard P. 1990. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343:369-372.
16. Hatchell PC, Collins AC. 1980. The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology (Berl) 71:45-49.
17. Heath AC, Kirk KM, Meyer JM, Martin NG. 1999. Genetic and social determinants of initiation and age at onset of smoking in Australian twins. Behav Genet 29:395-407.
18. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. 1991. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119-1127.
19. Hemmings HC Jr, Greengard P, Tung HY, Cohen P. 1984. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310:503-505.
20. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. 2004. Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol 26:61-69.
21. Kalivas PW. 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75-113.
22. Lange C, Silverman EK, Xu X, Weiss ST, Laird NM. 2003. A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics 4:195-206.
23. Li MD, Cheng R, Ma JZ, Swan GE. 2003a. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98:23-31.
24. Li MD, Ma JZ, Cheng R, Dupont RT, Williams NJ, Crews KM, Payne TJ, Elston RC. 2003b. Agenome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet 4 Suppl 1:S103.
25. Li MD, Ma JZ, Beuten J. 2004. Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66:382-392.
26. Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, Garcia V, Duenes AS, Crews KM, Elston RC. 2005. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14:1211-1219.
27. Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD. 2005. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 14:1691-1698.
28. Madden PA, Heath AC, Pedersen NL, Kaprio J, Koskenvuo MJ, Martin NG. 1999. The genetics of smoking persistence in men and women: A multicultural study. Behav Genet 29:423-431.
29. Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA. 2002. DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens. Nat Neurosci 5:641-648.
30. Nisell M, Nomikos GG, Svensson TH. 1994. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36-44.
31. Nyholt DR. 2004. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769.
32. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63: 259-266.
33. Perez-Stable EJ, Herrera B, Jacob P III, Benowitz NL. 1998. Nicotine metabolism and intake in black and white smokers. JAMA 280:152-156.
34. Perkins KA, Donny E, Caggiula AR. 1999. Sex differences in nicotine effects and self-administration: Review of human and animal evidence. Nicotine Tob Res 1:301-315.
35. Picciotto MR. 2003. Nicotine as a modulator of behavior: Beyond the inverted U. Trends Pharmacol Sci 24:493-499.
36. Picciotto MR, Corrigall WA. 2002. Neuronal systems underlying behaviors related to nicotine addiction: Neural circuits and molecular genetics. J Neurosci 22:3338-3341.
37. Pontieri FE, Tanda G, Orzi F, Di Chiara G. 1996. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
38. Robinson SF, Marks MJ, Collins AC. 1996. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl) 124:332-339.
39. Straub RE, Sullivan PF, Ma Y, Myakishev MV, Harris-Kerr C, Wormley B, Kadambi B, Sadek H, Silverman MA, Webb BT, Neale MC, Bulik CM, Joyce PR, Kendler KS. 1999. Susceptibility genes for nicotine dependence: A genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiatry 4:129-144.
40. Sullivan PF, Kendler KS. 1999. The genetic epidemiology of smoking. Nicotine Tob Res 1 Suppl 2:S51-S57; discussion S69-S70.
41. Swan GE. 2003. The need for dissemination of evidence-based results from research on nicotine and tobacco. Nicotine Tob Res 5:7-8.
42. Tyndale RF. 2003. Genetics of alcohol and tobacco use in humans. Ann Med 35:94-121.
43. Uhl GR, Vandenbergh DJ, Rodriguez LA, Miner L, Takahashi N. 1998. Dopaminergic genes and substance abuse. Adv Pharmacol 42:1024-1032.
44. Walaas SI, Greengard P. 1984. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 4:84-98.
45. Wang D, Ma JZ, Li MD. 2005. Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis. Pharmacogenomics J 5:166-172.
46. WHO. 2005. The world health report 2005. Geneva, Switzerland: World Health Organization, WHO Press.